Novel findings on the metabolic effects of the low glycaemic carbohydrate isomaltulose (Palatinose™)
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The slow digestible disaccharide isomaltulose (iso; Palatinose™) is available as novel functional carbohydrate ingredient for manufacturing of low glycaemic foods and beverages. Although basically characterised, various information on physiological effects of iso are still lacking. Thus, the objective of the present study was to expand scientific knowledge of physiological characteristics of iso by a set of three human intervention trials. Using an ileostomy model, iso was found to be essentially absorbed, irrespective of the nature of food (beverage and solid food). Apparent digestibility of 50 g iso from two different meals was 95·5 and 98·8 %; apparent absorption was 93·6 and 96·1 %, respectively. In healthy volunteers, a single dose intake of iso resulted in lower postprandial blood glucose and insulin responses than did sucrose (suc), while showing prolonged blood glucose delivery over 3 h test. In a 4-week trial with hyperlipidaemic individuals, regular consumption of 50 g/d iso within a Western-type diet was well tolerated and did not affect blood lipids. Fasting blood glucose and insulin resistance were lower after the 4-week iso intervention compared with baseline. This would be consistent with possible beneficial metabolic effects as a consequence of the lower and prolonged glycaemic response and lower insulinaemic burden. However, there was no significant difference at 4 weeks after iso compared with suc. In conclusion, the study shows that iso is completely available from the small intestine, irrespective of food matrix, leading to a prolonged delivery of blood glucose. Regular iso consumption is well tolerated also in subjects with increased risk for vascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
International Tables of Glycemic Index and Glycemic Load Values: 2008
Atkinson, F. S., Foster-Powell, K., & Brand-Miller, J. C. (2008) · Diabetes Care · doi:10.2337/dc08-1239 · Cited by 1,965
Low–Glycemic Index Diets in the Management of Diabetes
Brand-Miller, J., Hayne, S., Petocz, P., & Colagiuri, S. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2261 · Cited by 951
Liu, S., Manson, J. E., Stampfer, M. J., Holmes, M. D., Hu, F. B., Hankinson, S. E., & Willett, W. C. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.3.560 · Cited by 454
Livesey, G., Taylor, R., Hulshof, T., & Howlett, J. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.258s · Cited by 439
Meta-analysis of the health effects of using the glycaemic index in meal-planning
Opperman, A. M., Venter, C. S., Oosthuizen, W., Thompson, R. L., & Vorster, H. H. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041203 · Cited by 192 · cited 2×
“Meta-analyses demonstrated that studies in patients with type 2 diabetes showed beneficial effects of low GI/GL diets reflected in decreased HbA1c, fructosamine((29,31)) as well as HOMA-IR, fasting blood glucose and insulin levels((4)).”
Cited by
Impact of postprandial glycaemia on health and prevention of disease
Blaak, E. E., Antoine, J. ‐., Benton, D., Björck, I., Bozzetto, L., Brouns, F., Diamant, M., Dye, L., Hulshof, T., Holst, J. J., et al. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01011.x · Cited by 477
Self-citationBarazzoni, R., Deutz, N. E. P., Biolo, G., Bischoff, S., Boirie, Y., Cederholm, T., Cuerda, C., Delzenne, N., Leon Sanz, M., Ljungqvist, O., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.09.010 · Cited by 112
High glycemic index metabolic damage – a pivotal role of GIP and GLP-1
Pfeiffer, A. F. H., & Keyhani-Nejad, F. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.03.003 · Cited by 74
“Slow (Isomaltulose) versus Fast (Sucrose) Sugars: Different Intestinal Hormone Responses Administration of 50 g isomaltulose results in smaller peak increases in glucose than sucrose in healthy individuals [18,19] (Figure 1) and in people with type 2 diabetes [20].”
Low Glycemic Index Prototype Isomaltulose—Update of Clinical Trials
Maresch, C. C., Petry, S. F., Theis, S., Bosy-Westphal, A., & Linn, T. (2017) · Nutrients · doi:10.3390/nu9040381 · Cited by 53
“Isomaltulose has been categorized as “generally recognized as safe” (GRAS) in the USA and has been approved following pre-market safety assessment as a food ingredient under the Novel Food regulation in the European Union in 2005 [14] as well as in Australia and New Zealand in 2007.”
BackgroundInfluentialSelf-citationKönig, D., Theis, S., Kozianowski, G., & Berg, A. (2012) · Nutrition · doi:10.1016/j.nut.2011.09.019 · Cited by 48
Self-citation
Metadata
- Authors
- Holub, I., Gostner, A., Theis, S., Nosek, L., Kudlich, T., Melcher, R., & Scheppach, W.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2010-03-09
- Volume
- 103
- Issue
- 12
- Pages
- 1730-1737
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W2159999527
- Cited by
- 125
- References
- 6
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel findings on the metabolic effects of the low glycaemic carbohydrate isomaltulose (Palatinose™). https://app.cochat.ai/papers/10.1017/s0007114509993874
- The paper
- Holub, I., Gostner, A., Theis, S., Nosek, L., Kudlich, T., Melcher, R., & Scheppach, W. (2010). Novel findings on the metabolic effects of the low glycaemic carbohydrate isomaltulose (Palatinose™). British Journal of Nutrition. https://doi.org/10.1017/s0007114509993874
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.